XTL Biopharmaceuticals Ltd. (XTLB)

XTL Biopharmaceuticals Revenue

In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K. XTL Biopharmaceuticals had revenue of $405.00K in the quarter ending December 31, 2024.

• Revenue (ttm): $451.00K
• Revenue Growth: n/a
• P/S Ratio: 24.61
• Revenue / Employee: $64,429
• Employees: 7
• Market Cap: 11.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	451.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.